GI CONNECT’s Post

Didn't make it to #ASCO24? Don't worry, we've got you covered with an update on new NSCLC data ⬇️ Prof. Nicolas Girard joined us at the congress to share his views on new clinical trial data on oncogene-addicted non-small cell lung cancer. Watch his video update below📺 You can also download the accompanying slides for details of the trials: 👉 https://lnkd.in/dbXKkcY2 #MedicalEducation #oncology Supported by an Independent Medical Education Grant from Bayer.

We are delighted that ClinicalPath, our oncology decision support solution, is showcased in the Cancer Moonshot Fact Sheet released by The White House. This year, ClinicalPath plans to launch new capabilities that will prompt oncologists to incorporate precision medicine into their treatment decision-making. This will help to ensure cancer patients have access to innovative precision medicine treatment, including the latest clinical trials. We’re excited about how ClinicalPath can support oncologists at the point of care and are very proud to be included in this fact sheet – you can find it here – bit.ly/4jt0tHS #ClinicalPath #CancerMoonShot #PrecisionMedicine #oncology #Elsevier

Results from a new U.S. patient survey reveal the impact of metastatic colorectal cancer (#mCRC) on patient health-related quality of life.     The survey, conducted in collaboration with BLKHLTH, Family Reach, COLONTOWN and Colorectal Cancer Alliance, seeks to uncover actionable insights that will help guide the collective development of resources and education to support patients.    Read the full results that were presented at this year’s American Society of Clinical Oncology (ASCO)’s Quality Care Symposium: https://lnkd.in/enGqY4_D #CRC #crcsm 

From the rise of AI and liquid biopsies to the promise of personalized medicine, the future of cancer care is bright! Explore the transformative landscape of oncology in our latest whitepaper, where we dive into the trends driving progress in diagnostics. Join us in uncovering a brighter future for cancer treatment. Click to learn more. https://lnkd.in/dDqXrCRV #AIinOncology #PersonalizedMedicine #CancerCare #OncologyTrends #OncologyDiagnostics

Didn't make it to #ASCO24? Don't worry, we've got you covered with an update on new NSCLC data ⬇️ Prof. Nicolas Girard joined us at the congress to share his views on new clinical trial data on oncogene-addicted non-small cell lung cancer. Watch his video update below📺 You can also download the accompanying slides for details of the trials: 👉 https://lnkd.in/dbXKkcY2 #MedicalEducation #oncology Supported by an Independent Medical Education Grant from Bayer.

We are delighted that ClinicalPath, our oncology decision support solution, is showcased in the Cancer Moonshot Fact Sheet released by The White House. This year, ClinicalPath plans to launch new capabilities that will prompt oncologists to incorporate precision medicine into their treatment decision-making. This will help to ensure cancer patients have access to innovative precision medicine treatment, including the latest clinical trials. We’re excited about how ClinicalPath can support oncologists at the point of care and are very proud to be included in this fact sheet – you can find it here – bit.ly/4hoSERS #ClinicalPath #CancerMoonShot #PrecisionMedicine #oncology #Elsevier

We are delighted that ClinicalPath, our oncology decision support solution, is showcased in the Cancer Moonshot Fact Sheet released by The White House. This year, ClinicalPath plans to launch new capabilities that will prompt oncologists to incorporate precision medicine into their treatment decision-making. This will help to ensure cancer patients have access to innovative precision medicine treatment, including the latest clinical trials. We’re excited about how ClinicalPath can support oncologists at the point of care and are very proud to be included in this fact sheet – you can find it here – bit.ly/40GtgA3 #ClinicalPath #CancerMoonShot #PrecisionMedicine #oncology #Elsevier

Exciting news for breast cancer research! A new chapter by Dr. Kamal Saini and colleagues, published by Springer Nature, explores how Artificial Intelligence (AI) can revolutionize breast cancer treatment. The chapter dives into how AI can potentially: • Improve early detection • Help design more effective drugs • Combat drug resistance, a major challenge in treatment This research offers hope for a future where AI personalizes treatment and improves outcomes for breast cancer patients. https://lnkd.in/gdDN859F #BreastCancer #AIinHealthcare #DrugDiscovery #PersonalizedMedicine

Exciting news for breast cancer research! A new chapter by Dr. Kamal Saini and colleagues, published by Springer Nature, explores how Artificial Intelligence (AI) can revolutionize breast cancer treatment. The chapter dives into how AI can potentially: • Improve early detection • Help design more effective drugs • Combat drug resistance, a major challenge in treatment This research offers hope for a future where AI personalizes treatment and improves outcomes for breast cancer patients. https://lnkd.in/gihBNSPU #BreastCancer #AIinHealthcare #DrugDiscovery #PersonalizedMedicine

Exciting news for breast cancer research! A new chapter by Dr. Kamal Saini and colleagues, published by Springer Nature, explores how Artificial Intelligence (AI) can revolutionize breast cancer treatment. The chapter dives into how AI can potentially: • Improve early detection • Help design more effective drugs • Combat drug resistance, a major challenge in treatment This research offers hope for a future where AI personalizes treatment and improves outcomes for breast cancer patients. https://lnkd.in/gdyXcnXQ #BreastCancer #AIinHealthcare #DrugDiscovery #PersonalizedMedicine